Filter
3121
Text search:
adverse
health
effects
Featured
Recommendations
340
New Publications
754
Language
Document type
No document type
1636
Studies & Reports
535
Guidelines
534
Manuals
180
Strategic & Response Plan
101
Fact sheets
56
Training Material
45
Situation Updates
13
Infographics
7
Brochures
6
Resource Platforms
5
Videos
2
App
1
Countries / Regions
India
148
Global
136
Kenya
75
Western and Central Europe
72
South Africa
64
Ethiopia
61
Nepal
52
Uganda
51
Nigeria
47
Tanzania
41
Latin America and the Carribbean
40
Africa
39
Sierra Leone
37
Ghana
37
Zambia
35
Malawi
31
Philippines
29
Liberia
28
Myanmar / Burma
28
Bangladesh
27
Rwanda
23
Ukraine
23
South–East Asia Region
21
Zimbabwe
20
Namibia
19
Eastern Europe
19
Syria
18
Cambodia
17
Indonesia
15
East and Southern Africa
14
Asia
14
USA
12
Brazil
12
Guinea
11
South Sudan
11
Botswana
11
Eastern Europe and Central Asia
11
Senegal
10
Germany
10
Eswatini/ Swaziland
10
Congo, Democratic Republic of
9
Mozambique
9
Sudan
9
West and Central Africa
9
Middle East and North Africa
9
Russia
9
Thailand
8
Lesotho
8
Western Pacific Region
8
Burkina Faso
7
Yemen
6
Venezuela
6
Pakistan
5
Colombia
5
Moldova
5
Mali
4
Jordan
4
Afghanistan
4
China
4
Sri Lanka
4
Cameroon
3
Niger
3
Haiti
3
Somalia
3
Lebanon
3
Egypt
3
Madagascar
3
Laos
3
Iraq
2
Gambia
2
Singapore
2
Benin
2
Central African Republic
2
Argentina
2
North Macedonia
2
Ecuador
2
Angola
2
Chile
2
Paraguay
2
Palestine
2
Timor Leste/ East Timor
2
Tajikistan
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
North America
2
Belarus
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Chad
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Vanuatu
1
Peru
1
Burundi
1
Honduras
1
El Salvador
1
Greece
1
Guatemala
1
Other region
1
Fiji
1
Solomon Islands
1
Bhutan
1
Poland
1
Albania
1
Djibouti
1
Canada
1
Romania
1
Lithuania
1
Iran
1
Kazakhstan
1
Turkmenistan
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
949
Clinical Guidelines
346
Public Health
182
Women & Child Health
182
Key Resources
171
Capacity Building
46
Pharmacy & Technologies
29
Toolboxes
Mental Health
349
COVID-19
244
TB
200
HIV
193
Planetary Health
181
Pharmacy
102
NTDs
101
NCDs
95
AMR
82
Caregiver
80
Ebola & Marburg
62
Conflict
62
Global Health Education
60
Refugee
53
Disability
48
Rapid Response
45
Malaria
44
Specific Hazards
37
Natural Hazards
35
2.0 Rapid Response
29
Zika
22
Health Financing Toolbox
20
Polio
14
Cholera
10
Social Ethics
5
Typhoon
2
This resource was written to support persons who seek to initiate a support group for suicide loss survivors. Suicide bereavement support groups offer a wide range of benefits that can help individuals to navigate the difficult time following a loss. First and foremost, a support group provides a ch
...
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for
...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets
...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
1 February 2021 to 31 January 2022
Abridged version. In this abridged version of the Evidence-based Clinical Practice Guidelines for the Follow-Up of at-risk neonates, we provide recommendations for the care of newborns up to 2 years of age, corresponding to the first phase of their follow-up. The recommendations are intended for all
...
In 2018 and early 2019, the WHO Regional Office for Europe’s cultural contexts of health and well-being project worked alongside the University of Exeter’s WHO Collaborating Centre on Culture and Healt
...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t
...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as
...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to suppor
...
The guide contains valuable tools for wound care and the rehabilitation of people affected by Buruli ulcer. It is also helpful for peripheral health centres in areas where Buruli ulcer is endemic and to people and their families affected by the dise
...
